Home » test already available on the market for early and precise diagnoses

test already available on the market for early and precise diagnoses

by admin
test already available on the market for early and precise diagnoses

A new examination of blood could revolutionize the early diagnosis of the disease Alzheimer, allowing it to be identified well before symptoms appear. The test, already available on the market, measures the levels of p-tau 217 protein (biomarker for early Alzheimer’s disease) and, according to the authors of a study published in Jama Neurology, could be used to screen for the disease in the over-age population. 50.

Alzheimer’s, here are the first symptoms

See also  Covid, prof. Massimo Galli: "Vaccines avoid going to the cemetery, but they don't avoid infections" - La7 News

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy